Joseph Gonzalez

Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

Andres Forero, James N. Ingle, Vered Stearns, 2013, Clinical Cancer Research.

Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer

D. Lake, C. Hudis, L. Norton, 2011, Breast Cancer Research and Treatment.

Targeting the androgen receptor (AR) in women with AR+ ER-/PR- metastatic breast cancer (MBC).

C. Hudis, Minetta C. Liu, L. Carey, 2012 .